Brian T Fife
- University of Minnesota · Microbiology & Immunology (NIH department code)
- University of Minnesota · Internal Medicine (NIH department code)
From the FY2025 NIH awards this investigator leads as contact PI. The department is the award's.
FY2025 NIH rank #3,744
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 6146663Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Microbiology & Immunology
- Internal Medicine
NIH Funding · FY2025
Linked Award Amount
$2.8M
Full award amounts, FY2025
Award Records
2
Records listing this PI
Award-Linked Rank
#3,744
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Brian T Fife as a PI. Multi-PI records show the full award amount for context.
- 1R01DK144460-01R01Contact PIEngineering Tregs for autoimmune diabetes therapyUniversity of Minnesota · Microbiology & Immunology (NIH department code)$2.2Maward amount
- 5R01AI156276-05R01Contact PIIdentifying and preventing antigen specific T cells in diabetesUniversity of Minnesota · Internal Medicine (NIH department code)$590.3Kaward amount
Award organization
Organizations that administered FY2025 awards listing Brian T Fife as a PI.
FY2025 award administered by University of Minnesota (MN).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of Minnesota
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #7452
- 2025$2M Cumulative Funding
- 2025Entered Top 25% NationallyRanked #3744
- 2025R01 Grant Holder
- 2026$5M Cumulative Funding